Cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder Xylazine Masking Benzodiazepine Withdrawal PDF $40.00
$40.00
× Placeholder Escitalopram Treatment for Depressive Disorder Following Acute Coronary Syndrome: A 24-Week Double-Blind, Placebo-Controlled Trial PDF $40.00
$40.00
× Placeholder Aripiprazole for Treatment-Resistant Schizophrenia: Results of a Multicenter, Randomized, Double-Blind, Comparison Study Versus Perphenazine PDF $40.00
$40.00
× Placeholder Treatment Nonadherence and Neurocognitive Impairment in Bipolar Disorder PDF $40.00
$40.00
× Placeholder Translating Molecular Advances in Fragile X Syndrome Into Therapy: A Review PDF $40.00
$40.00
× Placeholder Response to Missile Attacks on Civilian Targets in Patients With Panic Disorder. PDF $40.00
$40.00
× Placeholder Risk and Protective Factors for Suicide Mortality Among Patients With Alcohol Dependence PDF $40.00
$40.00
× Placeholder Resource Utilization and Costs Associated With Insomnia Treatment in Patients With Major Depressive Disorder PDF $40.00
$40.00

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.


Join Now

Cart totals

Subtotal $320.00
Total $320.00
Proceed to checkout

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe